{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:29:15Z","timestamp":1791415755177,"version":"4.3.3"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2011,2]]},"abstract":"<jats:p>\n                    Angiotensin II type 2 receptor (AT\n                    <jats:sub>2<\/jats:sub>\n                    R) counteracts most effects of angiotensin II type 1 receptor (AT\n                    <jats:sub>1<\/jats:sub>\n                    R). We hypothesized that direct AT\n                    <jats:sub>2<\/jats:sub>\n                    R stimulation reduces renal production of the inflammatory cytokines tumor necrosis factor-\u03b1 (TNF-\u03b1), interleukin-6 (IL-6), and transforming growth factor-\u03b21 (TGF-\u03b21) and enhances the production of nitric oxide (NO) and cyclic guanosine 3\u2032,5\u2032-monophosphate (cGMP) in the clipped kidney of 2-kidney, 1-clip (2K1C) hypertension rat model. We used Sprague-Dawley rats to evaluate changes in renal interstitial fluid recovery levels of TNF-\u03b1, IL-6, NO, and cGMP; renal expression of AT\n                    <jats:sub>1<\/jats:sub>\n                    R, AT\n                    <jats:sub>2<\/jats:sub>\n                    R, TGF-\u03b21, TNF-\u03b1, and IL-6 in sham and 2K1C rats treated for 4 days with vehicle, AT\n                    <jats:sub>2<\/jats:sub>\n                    R agonist compound 21 (C21), or AT\n                    <jats:sub>2<\/jats:sub>\n                    R antagonist PD123319 (PD), alone and combined (n=6, each group). Systolic blood pressure increased significantly in 2K1C and was not influenced by any treatment. Clipped kidneys showed significant increases in renal expression of AT\n                    <jats:sub>1<\/jats:sub>\n                    R, AT\n                    <jats:sub>2<\/jats:sub>\n                    R, TNF-\u03b1, IL-6, TGF-\u03b21 and decreases in NO and cGMP levels. These factors were not influenced by PD treatment. In contrast, C21 caused significant decrease in renal TNF-\u03b1, IL-6, TGF-\u03b21 and an increase in NO and cGMP levels. Combined C21 and PD treatment partially reversed the observed C21 effects. Compared to sham, there were no significant changes in TNF-\u03b1, IL-6, TGF-\u03b21, NO, or cGMP in the nonclipped kidneys of 2K1C animals. We conclude that direct AT\n                    <jats:sub>2<\/jats:sub>\n                    R stimulation reduces early renal inflammatory responses and improves production of NO and cGMP in renovascular hypertension independent of blood pressure reduction.\n                  <\/jats:p>","DOI":"10.1161\/hypertensionaha.110.164202","type":"journal-article","created":{"date-parts":[[2010,12,28]],"date-time":"2010-12-28T20:59:27Z","timestamp":1293569967000},"page":"308-313","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":139,"title":["Angiotensin AT\n                    <sub>2<\/sub>\n                    Receptor Stimulation Inhibits Early Renal Inflammation in Renovascular Hypertension"],"prefix":"10.1161","volume":"57","author":[{"given":"Luis C.","family":"Matavelli","sequence":"first","affiliation":[{"name":"From the Department of Medicine, University of Virginia Health System, Charlottesville, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiqian","family":"Huang","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Virginia Health System, Charlottesville, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmy M.","family":"Siragy","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, University of Virginia Health System, Charlottesville, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1177\/1470320309347786"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1999.276.1.F39"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.30.5.1238"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1999.277.3.F437"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2009.09.002"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1998.274.1.F148"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V95763"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00476.2002"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00014.2007"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119531"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000090323.58122.5c"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc4601.099404"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.11.6506"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2007.11.006"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm049715t"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.108.784868"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3283311ba1"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.109.147843"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2009-0442"},{"key":"e_1_3_3_21_2","first-page":"170","article-title":"Unraveling the mystery of Goldblatt hypertension","volume":"13","author":"Navar LG","year":"1998","unstructured":"Navar LG, Zou L, Von Thun A, Tarng Wang C, Imig JD, Mitchell KD. Unraveling the mystery of Goldblatt hypertension. News Physiol Sci. 1998;13:170\u2013176.","journal-title":"News Physiol Sci"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000027105.02327.48"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.0500"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1006\/jsre.1995.1144"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000128022.24598.4f"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000164571.77710.19"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.33.1.96"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2008.08.009"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.64.s86.5.x"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.7521"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.9669"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199917121-00015"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00059.2006"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI27699"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00503.2009"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011161"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000138070.47616.9d"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118630"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.110.164202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T05:25:32Z","timestamp":1715577932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.110.164202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.110.164202"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.110.164202","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"2010-10-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-11-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-12-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}